The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2017

Filed:

Dec. 04, 2012
Applicant:

Centro DE Immunologia Molecular, La Habana, CU;

Inventors:

Adys González Palomo, La Habana, CU;

Adriana Carr Perez, La Habana, CU;

Kalet León Monzón, La Habana, CU;

Rancés Blanco Santana, La Habana, CU;

María del Carmen Barroso Alvarez, La Habana, CU;

Amparo Emilia Macías Abraham, La Habana, CU;

José Enrique Montero Casimiro, La Habana, CU;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01); C07K 16/42 (2006.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61K 39/0011 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); C07K 16/3084 (2013.01); C07K 16/4266 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.


Find Patent Forward Citations

Loading…